HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Agnus Castus Fruit PMS Study, Pro-CAM Editorials Featured On BMJ

This article was originally published in The Tan Sheet

Executive Summary

Chaste fruit extract is both safe and effective in treating the symptoms of premenstrual syndrome, according to a study in the Jan. 20 British Medical Journal. The study is one of several articles on complementary and alternative medicine that appear in the issue.

You may also be interested in...



Supplement bibliography

Third 1Annual Bibliography of Significant Advances in Dietary Supplement Research includes five abstracts each on water-, fat-soluble vitamins out of 25 total research papers summarized in publication. Joint effort by CHPA, ODS, released Oct. 16, features more human subject data than previous editions. Bibliography includes science-based research demonstrating positive effects of chaste tree for PMS symptoms, ginger supplements for pregnancy-related nausea (2"The Tan Sheet" Jan. 29, 2001, p. 5) and (3"The Tan Sheet" April 16, 2001, In Brief). New edition also includes appendix listing studies from previous two publications so interested parties can analyze research trends...

White House CAM Commission Debates Medical Education

The current status and potential of complementary and alternative medicine education in medical schools were discussed at the inaugural meeting of the White House Commission on Complementary & Alternative Medicine Policy in Washington, D.C. July 13-14.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS131303

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel